Learn more

HEMOFARM KONCERN A D

Overview
  • Total Patents
    13
About

HEMOFARM KONCERN A D has a total of 13 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Serbia, Yugoslavia (Serbia and Montenegro) and Australia. Its main competitors in its focus markets pharmaceuticals are XIA XIUFEI, GUO MINZHAO and HUA JU.

Patent filings in countries

World map showing HEMOFARM KONCERN A Ds patent filings in countries

Patent filings per year

Chart showing HEMOFARM KONCERN A Ds patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

# Technology
#1 Medical preparations

Top inventors

# Name Total Patents
#1 Petrovic Slobodan 10
#2 Bugarski Branko 4
#3 Pavkov Ruzica 4
#4 Golic Spomenka 4
#5 Stojanovic Nevenka 3
#6 Dovezenski Nebojsa 3
#7 Bugarski Diana 3
#8 Avramov-Ivic Milka 2
#9 Palurovic Branka 2
#10 Mijin Dusan 2

Latest patents

Publication Filing date Title
RS20050091A Pharmaceutical kit of non-fixed combination of ace inhibitor tablets and non-thiazide diuretic in hypertension treatment
RS116004A Diclofenack stick and procedure for its obtaining
YU25403A Procedure for obtaining day cream based on combination of enzymes, vitamins and provitamins
YU25303A Procedure for obtaining night cream based on combination of enzymes, vitamins and provitamins
YU87003A Emulsion containing hydrophobic nanodrops with bound hemoglobin molecules in a hydrophilic phase as a blood substitute
YU72302A Product based on liposoms with incapsulated clindamicine for treatment of young acknae and production procedure thereof
YU72402A Procedure for obtaining enriched night cream for treatment of aged skin
YU28502A The enzymemucopolysaccharidase based preparation for treatment of cellulitis and process for their obtaining
YU17502A New diagnostic method for spectroscopic detection of tuberculosis and diagnostic set
YU87701A Individual substrate stabilization prodedure for spectroscopis detection of malignancy
YU80601A Procedure for obtaining new substituted 2-phenylacetamide